Her research is focused on developing new diagnostic and therapeutic approaches to the management of pre-malignancy in the breast and cervix. She is studying genetic pathways and signaling pathways that regulate programmed cell death following lactation to see how they can be applied to the problem of cancer regression.

Cancer progression and regression, hormonal signaling pathways, estrogen receptor alpha signaling, prolactin and Stat5a signaling. Her research interests include: reversal of preneoplasia, breast cancer pathogenesis, transgenic mouse models of carcinogenesis.